General Information of DTT (ID: TT1ERKL)

DTT Name CD40 messenger RNA (CD40 mRNA) DTT Info
Gene Name CD40

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
NJA-730 DM4I02O Graft-versus-host disease 4B24 Phase 1 [1]
------------------------------------------------------------------------------------
8 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS 19211 DMKFCD5 Discovery agent N.A. Investigative [2]
ISIS 19212 DMLQT5F Discovery agent N.A. Investigative [2]
ISIS 19213 DMD1JVZ Discovery agent N.A. Investigative [2]
ISIS 19217 DMQK0AL Discovery agent N.A. Investigative [2]
ISIS 19218 DMX4I5A Discovery agent N.A. Investigative [2]
ISIS 19219 DMFAWGX Discovery agent N.A. Investigative [2]
ISIS 19220 DMIKEXD Discovery agent N.A. Investigative [2]
ISIS 19221 DMKOFNX Discovery agent N.A. Investigative [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Investigative Drug(s)
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of NapaJen Pharma.
2 US patent application no. 6,197,584, Antisense modulation of CD40 expression.